Zhenyu Yang

Zhenyu Yang

Auto-generated profile, based on publicly available information

Zhenyu Yang

Department of Thoracic Surgery, Institute of Thoracic Oncology, West China Hospital, Sichuan University, Chengdu, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2024 in International Journal of Surgery
Verified
Journal Article
Open access
CLChengwu Liu
Chengwu Liu
ZYZhenyu Yang
Zhenyu Yang
YLYiming Li
Yiming Li
CGChenglin Guo
Chenglin Guo
LXLiang Xia
Liang Xia
LLLunxu Liu
Lunxu Liu
Background: Whether wedge resection is oncological suitable for ground glass opacity (GGO)-dominant non-small cell lung cancer (NSCLC) ≤2 cm is still debatable. The aim of this study is to investigate the short-term and long-term outcomes of intentional wedge resection and segmentectomy for those patients. Materials and Methods: This was a real-world study from one of the largest thoracic surgery centers in West China. Patients who underwent intentional wedge resection or segmentectomy for ≤2 cm CTR (consolidation-to-tumor) ≤0.5 NSCLC were consecutively included between December 2009 and December 2018. Data were prospectively collected and retrospectively reviewed. Inverse probability of treatment weighting (IPTW) was used to balance baseline characteristics. Long-term outcomes, including overall survival (OS), recurrence-free survival (RFS), and lung cancer-specific survival (LCSS), were analyzed using Cox proportional model. Results: A total of 1209 patients were included (497 in the wedge resection group, 712 in the segmentectomy group). Compared to segmentectomy, wedge resection had a significantly lower rate of complications (3.8 vs. 7.7%, P=0.008), a shorter operating time (65 min vs. 114 min, P<0.001), and a shorter postoperative stay (3 days vs. 4 days, P<0.001). The median follow-up was 70.1 months. The multivariate Cox model indicated that wedge resection had survival outcomes that were similar to segmentectomy in terms of 5-year OS (98.8 vs. 99.6%, HR=1.98, 95% CI: 0.59–6.68, P=0.270), 5-year RFS (98.8 vs. 99.5%, HR=1.88, 95% CI: 0.56–6.31, P=0.307) and 5-year LCSS (99.9 vs. 99.6%, HR=1.76, 95% CI: 0.24–13.15, P=0.581). Conclusion: Intentional wedge resection is an appropriate choice for ≤2 cm GGO-dominant NSCLC.

26 January 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
ZYZhenyu Yang
Zhenyu Yang
SWShiyou Wei
Shiyou Wei
HDHao Duan
Hao Duan
XWXiuqi Wang
Xiuqi Wang
DZDainan Zhang
Dainan Zhang
GZGao Zhang
Gao Zhang
The molecular heterogeneity of brain metastases hampers therapeutic development for cures. To address this unmet and urgent need, we construct a comprehensive multi-omic, single cell, and spatially resolved atlas of 1,032 pan-cancer brain metastases, identifying four robust molecular subtypes with distinct biological programs and clinical associations. These brain metastases subtypes (BrMS) are defined by unique biological states: neural-like (BrMS1), metabolic (BrMS3), highly proliferative/immune-excluded (BrMS4), and an immune-infiltrated (BrMS2) state featuring a coordinated epithelial-mesenchymal transition program. Patient-derived organoids coupled with targeted drug screening indicate subtype-specific molecular dependencies and putative targets, notably mTOR signaling activation in BrMS3 and CDK4/6 axis activation in BrMS4, while BrMS1 and BrMS2 display distinct radiobiologic and immunologic signatures. This atlas provides a rigorous classification framework of BrMs and offers insights into subtype-specific molecular vulnerabilities.

24 June 2024 in International Journal of Surgery
Verified
Journal Article
Open access
ZYZhenyu Yang
Zhenyu Yang
YLYiming Li
Yiming Li
CGChenglin Guo
Chenglin Guo
YXYikai Xing
Yikai Xing
CLChengwu Liu
Chengwu Liu
LLLunxu Liu
Lunxu Liu
Background: Visceral pleural infiltration (VPI) has been identified as an important risk factor in nonsmall cell lung cancer (NSCLC) for many decades. However, for patients who present with ground glass opacity (GGO), the prognostic value of VPI is still elusive. The authors aimed to investigate whether the VPI is a significant prognostic factor in surgically resected ≤3 cm stage I NSCLC, who presented with GGO. Materials and methods: Patients with primary NSCLC who underwent surgical resection between December 2009 and December 2018 were collected. Stage I tumors that presented as GGO nodules with a tumor size of less than 3 cm were included and divided into two groups based on VPI status (positive and negative). Clinical, pathological, and prognostic data were prospectively collected and retrospectively reviewed. Inverse probability of treatment weighting (IPTW) was used to balance baseline characteristics. Overall survival (OS) and recurrence-free survival (RFS) were analyzed using the Cox proportional hazards model and Kaplan–Meier method. Results: A total of 2043 patients were included in this study (VPIs were found in 196 patients). After IPTW weighting, all factors between the two groups were balanced. The median follow-up time was 67.3 months. According to the multivariable Cox models, the VPI was not a significant prognostic factor for OS (HR=2.00, 95% CI: 0.96–4.17; P=0.063), but was significant for RFS (HR=2.00, 95% CI: 1.12–3.55; P=0.019). In subgroup analysis, we found VPI was significant for OS (HR=3.17, 95% CI: 1.09–9.26, P=0.035) and RFS (HR=4.07, 95% CI: 1.76–9.40, P=0.001) in patients with a tumor size >1 cm and a consolidation to tumor ratio (CTR) >50%. For patients with a tumor size ≤1 cm or a CTR ≤50%, the VPI was not significant. Conclusions: VPI may be a significant risk factor for GGOs in NSCLC patients with a tumor size >1 cm and a CTR >50%. Further prospective studies conducted across multicenters with a larger sample size are needed.

8 July 2026 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
LYLinyu Yang
Linyu Yang
ZYZhenyu Yang
Zhenyu Yang
Tissue microenvironment heterogeneity, including cellular composition, functional states, and intercellular interactions, shapes complex biological process

15 April 2026 in Nature Communications
Verified
Journal Article
Open access
ZYZhenyu Yang
Zhenyu Yang
SWShiyou Wei
Shiyou Wei
HDHao Duan
Hao Duan
XWXiuqi Wang
Xiuqi Wang
DZDainan Zhang
Dainan Zhang
GZGao Zhang
Gao Zhang

27 October 2026
Verified
Journal Article
Open access
PDF file
XWXiuqi Wang
Xiuqi Wang
ZYZhenyu Yang
Zhenyu Yang
Brain metastases (BrM) exhibit variable intracranial responses to immune checkpoint blockade (ICB), and reliable biomarkers of benefit remain uncertain, possibly reflecting the distinctive brain microenvironment. This review discusses multiplex protein imaging, array-based spatial transcriptomics, and in situ RNA imaging as complementary approaches for studying BrM and summarizes findings on regional differences in immune access and tumor cell states, CD8+ T cell localization and tumor contact, macrophage-associated and perivascular niches, tertiary lymphoid structure (TLS) signatures and organization, and potentially tumor-reactive or progenitor-like exhausted T cell populations. The clinical significance of these features varies. TLS signatures and several immune cell measures have been associated with survival, whereas differences in T cell infiltration and perivascular macrophage organization have been reported between ICB-treated and ICB-naive BrM specimens. However, most studies are retrospective, rely on selected surgical specimens, and establish prognostic or treatment-associated relationships rather than prospectively validated predictors of anti-PD-1/PD-L1 benefit. Finally, the review considers how targeted, reproducible spatial measures could be benchmarked with conventional biomarkers and validated in prospective, tumor-type-specific intracranial cohorts before clinical use.